Left icon


Register Now!

Free Membership
for our Partner Institutions
Not in List?
We serve 200+ Institutions with limited Free Accounts or $19.95/1 Yr or $39.95/Lifetime Accounts
Not in List?
  • Search over 1500+ listings for MS, PhD and MD holders
  • Discounted Career Tools customized for life science postgraduates
  • Attend Webinars to expose you to varieties of career paths, experts and peers
  • Be able to join the Bio Careers Blog, where you can ask your career questions and find bloggers going through the same job transitions you are

  • Skepticism is overrated

    Leo Kim, Ph.D
    Career Paths
    Biopharma Research
    Rate this article:
    3

    The Dour and SourYes, that’s right. Those of us bred in academia, we are a bunch of pessimists. Or, at least industry people perceive us, so you’d better get used to a new norm if you are determined not to become an anachronism. Get it? No? Ok, here’s an example. Your company just completed a clinical trial. Data shows that drug treatment groups seem to be slightly better off than a placebo arm, but not in a statistically significant way. You describe the results to your Wall Street investors. You are a smart PhD with ingrained scientific rigor in your DNA, so you proceed as follows. “With a p-value greater than 0.05, there is more than a 1 in 20 chance that patient improvement in treatment arms is a consequence of mere random drift, therefore… ...